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AL- Acute leukaemia 
ALL – Acute lymphoid leukaemia 
AML – Acute myeloid leukaemia 
ANLL – Acute non-lymphoblastic leukaemia 
CNS – Central Nervous System 
GB – Great Britain 
LSS – Life Span Study 
RBM – Red bone marrow 











































































Empirical estimation of cancer risks in children associated with low-dose ionizing radiation (<100 
mSv) remains a challenge. The main reason is that the required combination of large sample sizes with 
accurate and comprehensive exposure assessment is difficult to achieve. An international scientific 
workshop “Childhood cancer and background radiation” organised by the Institute of Social and 
Preventive Medicine of the University of Bern brought together researchers in this field to evaluate 
how epidemiological studies on background radiation and childhood cancer can best improve 
understanding of the effects of low-dose ionising radiation. This review summarises and evaluates the 
findings of the existing studies in the light of their methodological differences, identifies key 
limitations and challenges and proposes ways forward. Large childhood cancer registries, such as 
those in Great Britain, France and Germany, now allow the conducting of studies that should have 
sufficient statistical power to detect the effects predicted by standard risk models. Nevertheless, larger 
studies or pooled studies will be needed to investigate disease subgroups. The main challenge is to 
accurately assess children’s individual exposure to radiation from natural sources and from other 
sources, as well as potentially confounding non-radiation exposures, in such large study populations.  
For this, the study groups should learn from each other to improve exposure estimation and develop 
new ways to validate exposure models with personal dosimetry. 
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Exposure to high doses of ionizing radiation is known to increase the risk of cancer. Standard risk 
models based on data from the Life Span Study (LSS) of atomic bomb survivors from Hiroshima and 
Nagasaki are broadly consistent with a linear/linear-quadratic increase in cancer risk with dose. The 
excess relative risk (ERR) per gray is modified by sex, age at exposure and time since exposure (1, 2). 
These variations are pronounced for leukaemia: ERR/Gy is highest after exposure in childhood and 
reaches a peak some 5 years after exposure (with ERR estimates of about 50 per Sv), declining 
thereafter (3). Evidence from other studies is also consistent with a higher risk of radiation induced-
cancer after exposure during childhood compared to exposure in later life for various cancer types 
including leukaemia, thyroid, skin, breast and brain cancer (4).  
The empirical estimation of excess cancer risks associated with low doses (<100 mGy low-LET 
radiation) is more difficult due to sample size requirements and the challenge of reliable dosimetry. 
However, a recent pooled analysis of nine cohort studies with individual dosimetry, including over 
260,000 people exposed to low doses during childhood from medical exposure and from the atomic 
bombs, found evidence of excess risks associated with doses of less than 50 mSv for acute leukaemia 
(5). The pooled analysis included a large cohort study from the UK that reported that cumulative doses 
to the red bone marrow (RBM) of about 50 mGy and to the brain of about 60 mGy (2-3 head CT 
scans) might almost triple the risk of leukaemia and brain tumours (6).  A recent nationwide cohort 
study in the Netherlands included 168,394 children who received one or more CT scans also reported 
that brain doses of about 20–50 mGy may increase brain tumour risk (7), but no association was 
observed for leukaemia. However, results from studies of paediatric CT scans need to be interpreted 
with caution, because of the potential for reverse causation and confounding by indication (8, 9). 
Children’s heightened susceptibility combined with short latency periods suggest that a meaningful 
proportion of leukaemia cases in children, and possibly also of central nervous system (CNS) tumours, 
might be caused by exposure to natural sources of radiation. Indeed, based on standard risk models, 
studies from Great Britain (GB) and France estimate this proportion to be up to about 20% (10, 11), 
and in Finland estimates were about 5% (unpublished results), albeit all with large uncertainties. 
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However, in the LSS, which commenced just over 5 years after the bombings and upon which the 
standard leukaemia risk models are based, only four cases of leukaemia occurred among survivors 
with attained age <10 years and their RBM doses were >1 Sv (12). So, caution is required in applying 
these risk models to children receiving very low annual doses. 
Most of the previous ecological studies investigating associations between childhood leukaemia and 
naturally occurring sources of ionising radiation have found positive associations for radon (13-15) 
while for gamma radiation and cosmic rays results have been inconsistent (16-22). Early case-control 
studies of the association between natural sources of radiation and childhood leukaemia were 
underpowered and have reported mixed results (23-26). The largest of these, the UK Childhood 
Cancer Study, included over 2000 cases of childhood cancer and reported weak evidence of a negative 
association between childhood leukaemia and measured radon concentrations (25) but no evidence of 
an association with measured gamma dose rates (26). However, the proportion of eligible subjects 
participating in the measurements was low and varied by socio-economic status. Because exposure to 
these sources is ubiquitous and variation in cumulative doses received by children of similar age are 
small, large sample sizes are needed to detect the small predicted risk. Given the rarity of childhood 
cancer, the only way to achieve such sample sizes is by combining data over long periods of 
systematic cancer registration.    
In the last decade, several nationwide record-based studies in Europe, also referred to as registry-based 
or register-based studies, have investigated associations between childhood cancer and natural sources 
of radiation including gamma radiation (with or without the cosmic component) (27-31) and domestic 
radon (27, 30, 32, 33). In contrast to questionnaire- or interview-based studies, record-based studies 
rely for the most part on comprehensive data compiled systematically for the entire population and do 
not require any active participation by study members. Exposure prediction models are used to 
estimate residential exposure to different sources of background radiation. 
The Institute of Social and Preventive Medicine of the University of Bern, Switzerland, organized the 
international scientific workshop “Childhood cancer and background radiation” on June 6th, 2018. 
The aim of the workshop was to bring together researchers in the field and interested parties from 
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around the world to discuss how epidemiological studies on background radiation and childhood 
cancer can improve understanding of the effects of low-dose ionising radiation. The studies presented 
at the workshop represent all studies that have been conducted based on nationwide registration of 
childhood cancers. 
The purpose of this review is to describe the findings of the existing studies and their methodological 
differences, identify limitations and challenges, and propose ways forward in this area of research. In 
the first section, we describe the methods and findings of the studies. The second section highlights the 
main methodological challenges, providing an inside view from the authors and presenters of the 
workshop. Finally, we conclude with future perspectives and recommendations for further research. 
Review of recent record-based studies 
In this section, we briefly summarize each of the record-based studies on natural sources of radiation 
and childhood cancer in chronological order of their publication (27-33). An overview of the 
methodological characteristics and findings is presented in Tables 1 and 2. More details on methods 
of assessing exposure to gamma radiation and residential radon are provided in Tables 3 and 4. All 
studies used cancer registries with high completeness to identify cases (31, 34-38). 
The first one was a Danish case-control study that examined domestic radon exposure (33). It included 
2,400 childhood malignancies (leukaemia, CNS, and malignant lymphoma) diagnosed in 1968-1994. 
Control children were selected from the Danish Central Population Registry matching on sex and year 
of birth. Exposure assessment covered all residences in which the child had lived between birth and 
diagnosis (or equivalent date). Domestic radon exposure was estimated using a regression model 
developed from measurements in the living rooms of 3,116 Danish dwellings, with predictors 
including geographical region, soil type, and house characteristics (39). The study found a relative risk 
(RR) of 1.56 per cumulative exposure of 103 Bq/m3-years (95% confidence interval (CI): 1.05, 2.30) 
for acute lymphoblastic leukaemia (ALL). No association was observed for childhood acute non-
lymphoblastic leukaemia (ANLL) or brain/CNS tumours, with RRs of 0.75 (95% CI: 0.34, 1.62) and 
0.92 (95% CI: 0.69, 1.22) per 103 Bq/m3-years, respectively. The exposure model performed relatively 
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well in predicting radon concentrations in a test sample of 758 independent measurements (coefficient 
of determination R2 = 0.45) (39). Background gamma radiation was not assessed. 
A large record-based case-control study from Great Britain (GB: England, Wales and Scotland) 
investigated associations of indoor radon and gamma exposure with various childhood cancers (30). It 
included 27,447 children diagnosed with cancer during 1980–2006 of which 9,058 were childhood 
leukaemia. For each case, a control was selected from the same birth register matching for sex and 
date of birth (within six months). Radiation exposures were estimated for mother’s residence at the 
child’s birth. Exposure to gamma radiation was estimated using the County District mean dose rates 
based on 2,283 indoor measurements made throughout GB. Exposure to radon was estimated using a 
predictive map based on approximately 400,000 measurements in homes throughout GB. Cumulative 
doses to the RBM since conception were calculated assuming residential exposures at the same dose 
rate as the residence of birth. The authors reported a RR for childhood leukaemia of 1.12 (95% CI: 
1.03, 1.22) per mSv cumulative equivalent dose to the RBM from terrestrial gamma and 1.03 (95% CI: 
0.96, 1.11) for RBM dose from domestic radon.  
In Switzerland, two studies, one on radon and another on gamma radiation, were conducted using data 
from a census-based cohort study (29, 32). Cases of childhood cancer were identified through 
probabilistic record linkage with the Swiss Childhood Cancer Registry (SCCR). Exposure to 
residential radon was estimated using a prediction model based on 35,706 indoor measurements and 
soil and building characteristics (tectonic units, soil texture, floor level and degree of urbanization) as 
predictors. In internal validation, the radon model had a relatively low R2 of 0.2. Outdoor dose rates 
from terrestrial gamma and cosmic radiation were estimated using a map developed by interpolation 
based on a diverse set of measurements including airborne spectrometry (40). Change of residence 
between censuses, but not full lifetime residential history, was taken into account to calculate time-
varying cumulative exposure. The study on radon exposure included 997 cases of childhood cancer 
and found no evidence of an association, neither for all cancers combined, nor for leukaemia nor CNS 
tumours. The study on exposure to gamma radiation included 1,782 cases and found evidence of 
associations for leukaemia and CNS tumours: for both diagnostic groups a RR of about 1.04 (95% CI: 
1.00, 1.08) per mSv cumulative whole-body dose was estimated. 
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A nationwide case-control study in Finland investigated association between exposure to gamma 
radiation and childhood leukaemia. It included 1,093 cases diagnosed over the period 1990-2011 (28). 
Three controls per case, individually matched on year of birth and sex, were selected from the national 
population register. Exposure was assessed using a map of terrestrial gamma radiation dose rate and a 
map of Chernobyl fallout. For cases with partially unknown residential history, municipal averages of 
terrestrial gamma dose rates were used. Exposure assessment accounted for type of building regarding 
shielding and the radiation from the building materials. Full residential history was available to 
calculate cumulative dose to the RBM. Overall, there was no evidence of an association for childhood 
leukaemia (RR 1.01, 95% CI: 0.97, 1.05 for 10 nSv/h increase in average equivalent dose rate to 
RBM). In subgroup analyses, leukaemia diagnosed at ages 2-6 years was associated with cumulative 
dose to the RBM (RR 1.27, 95% CI: 1.01, 1.60 per mSv).  
In France, a nationwide case-control study investigated the association of childhood acute leukaemia 
and background radiation (27). It included 2,761 cases diagnosed during 2002-2007 and 30,000 
controls sampled from a national dataset of households. Exposure to both radon and gamma radiation 
was based on cokriging models that combined indoor measurements – 17,404 for gamma (41) and 
10,843 for radon (42)  – with a map of geogenic radon/uranium potential (R²=0.32 for radon; R²=0.65 
for gamma). Exposure was assessed based on residence at time of diagnosis. Cumulative doses to the 
RBM from radon and gamma radiation were calculated assuming constant place of residence since 
birth. The authors reported an RR for childhood acute leukaemia of 1.00 (95% CI: 0.98, 1.01) per 
nSv/h of gamma radiation and 0.98 (95% CI: 0.90, 1.07) per 100 Bq/m3 of radon concentration.  
Recently, two ecological studies were conducted in France and Germany. In France, the ecological 
study assessed cancer risks and exposure across 36,326 municipalities and included 9,056 cases 
diagnosed between 1990 and 2009. Results were published in parallel with the aforementioned case-
control study (27) and used the same exposure models, but exposure was determined at the town 
centre for radon and at municipality-level means for gamma. Among the 30,000 controls in the case-
control study, the municipality-based estimates of exposure used in the ecological study correlated 
strongly with the estimates of exposure based on residential addresses: r = 0.975 for gamma exposure 
and r = 0.991 for radon exposure. The results were consistent in both studies and neither showed any 
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evidence of association between radon or gamma exposure and acute leukaemia or the subgroups ALL 
or AML. The RR for radon and gamma combined was 1.00 (95% CI 0.99-1.01) per mSv cumulative 
RBM dose for leukaemia.  
The recent nationwide ecological study from Germany (31) investigated childhood cancer risks and 
gamma ray exposure at the municipality level (11,292 municipalities).  The study included childhood 
cancer cases diagnosed during 1987-2011 with ALL (11,447 cases), AML (1,927 cases), CNS (9,048 
cases) and thyroid cancer (230 cases) and a set of childhood cancer diagnoses assumed a priori to be 
unrelated with radiation exposure (11,385 cases) (31). Exposure to terrestrial gamma radiation was 
assessed for the municipality of residence at diagnosis by interpolation of measured dose rates from 
the sites of the gamma monitoring network using inverse distance weighting. Data on radon exposure 
were not available. CNS tumour incidence rates were associated with annual ambient dose rate (RR 
comparing 1.5 to 0.5 mSv/a of 1.35; 95% CI: 1.17, 1.57). The study did not find evidence of an 
association with ALL or AML. The ambient dose rate data were extrapolated from 1,800 outdoor 
measuring sites to the 11,292 inhabited communities. Exposure was assessed only at time of diagnosis. 
Methodological challenges   
In contrast to earlier studies (14, 25, 26) that were often limited by potential for selection bias and/or 
limited statistical power (23, 43, 44) , the more recent record-based studies reviewed here do not require 
active participation of the study population. They thus can achieve larger sample sizes, while essentially 
avoiding selection bias.  
Kheifets et al. evaluated potential bias due to low participation in previous measurement-based studies 
compared to more recent record-based studies. Overall, associations were stronger for studies based on 
modelling as compared to ones with measurements. However, only the UK provides sufficient 
information for appropriate comparison (44). Despite this inherent advantage of studies that are purely 
record-based, achieving large sample sizes remains a challenge, particularly for countries with small 
population sizes such as Switzerland, Finland, or Denmark. The greatest challenge of record-based 
studies, however, is how to accurately assess individual exposure.   
Sample size and statistical power 
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Achieving sufficient statistical power is a key challenge of any epidemiological study assessing cancer 
risks associated with low-dose radiation. Statistical power depends not only on sample size and the 
magnitude of the expected effects, but also on the variability of the exposure between subjects. 
Three of the reviewed studies reported power calculations (27, 28, 30). For GB, Little et al. computed 
the number of years of comprehensive cancer registration that would be required to achieve sufficient 
sample sizes to detect the expected effects of radon and background gamma combined on childhood 
leukaemia risk (23). Depending on the study design the resulting numbers were: 14 years (6,400 cases) 
for a cohort study, 17 years (7,800 cases) for a case-control study with 5 controls per case and 19 years 
(8,700 cases) for an ecological study. The authors assumed the linear low-dose part of the BEIR V 
model derived from the Japanese data (ERR=32.1 Sv-1) and required 80% power for a 1-sided test at 
the 5% significance level. Larger samples are required for investigating effects of radon and gamma 
radiation separately (23).  
Despite the large sample size, the statistical power of the recent GB study to detect expected 
association between gamma ray exposure and childhood leukaemia risk was only about 50% (30); the 
geographic matching (by birth registration district) of cases and controls combined with the county 
district averaging resulted in about half of the cases having the same gamma dose rate estimate as their 
controls. The attempt to mitigate possible spatial confounding by regional matching reduced the 
exposure contrast between cases and controls and with that also the statistical power of the study.  For 
radon, there were considerably more measurements and the areal units were smaller, so this problem 
does not apply to the radon analysis, but the RBM dose is smaller and statistical power is much lower 
for this measure. 
The power of the recent French study (27) to detect the expected effects predicted by the 
multiplicative ERR model published by UNSCEAR (1) for leukaemia was 92.4% for gamma radiation 
exposure, 44.8% for radon exposure, and 99.4% for total gamma and radon exposure combined. 
Statistical power was higher for assumed ERRs of 5% and 10% per mSv, which correspond to effect 
sizes an order of magnitude greater than that found in the GB and Swiss studies. Despite this, no 
evidence of an association was found, while confidence intervals were incompatible with those of the 
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study from GB. This discrepancy is unlikely to be due to chance, suggesting that there are biases in 
either or both studies, or that the effects genuinely differ. The timing of the exposure assessment, 
which was at birth in the study from GB and at diagnosis in the French study, is one apparent 
methodological difference that might partially explain the difference. Assuming that early life 
exposure has a greater effect on cancer risk, exposure assessment at birth should give larger effect 
estimates (4, 45). However, this explanation is tenable only if residential mobility, i.e. moving home 
between birth and diagnosis, causes large and systematic differences in exposure between birth and 
diagnosis, which seems unlikely (see below for a discussion on residential mobility and potential 
biases). 
If the sample size calculations by Little et al. are used as a reference, the smaller studies conducted in 
Switzerland, Finland, and Denmark were markedly underpowered. However, in countries with greater 
exposure variability and/or levels, smaller samples are needed to achieve the same statistical power 
and precision of estimates. In the Swiss study, for instance, gamma-ray dose rate ranged from 55 to 
383 nSv/hr (mean 109 nSv/hr) compared to 38-160 nGy/hr (mean 95 nGy/hr) in GB as used in the 
generic calculations of Little et al. It should be noted that in the GB study of Kendall et al. controls 
were chosen from the same birth registration district as the case, so the power of this study will be 
determined by the variability of dose rates within these districts.  Bespoke power calculations for the 
study of Kendall et al. were carried out and reported in that paper.  The Finnish study had a statistical 
power of 80% for detecting a linear dose-response with OR of 1.06 or greater per 10 nSv h-1 increase 
in dose rate. For radon, the differences in exposure variability are larger between countries than for 
gamma radiation (Table 3).  
The uncertainty of dose estimates was not accounted for in the power calculations cited above. Its 
impact could be important (46), but to take it into account would require appropriately specified 
measurement error models. Further calculations on statistical power that account for the differences in 
exposure distribution by country and for measurement error are needed.  
Separate power calculations are also needed for the investigation of diagnostic subgroups including 
the cytogenetic subtypes of leukaemia, which may differ in their aetiology. Recurrent cytogenetic 
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alterations are important prognostic indicators. However, the epidemiological study of such subtypes 
has only recently begun (47). Of the studies presented in this review, only the Finnish study 
investigated genetic subtypes and results suggested a larger effect of radiation on leukaemia with high 
hyperdiploidy than other subgroups.  
Exposure assessment and measurement error 
One of the reasons why previous studies have focused on residential radon and terrestrial gamma 
radiation, and not for instance on ingested radionuclides, is that the former natural sources of radiation 
show distinct and measurable spatial variation. Such spatial variation can be exploited for exposure 
assessment in record-based studies based on residential information. Some countries, particularly 
those with considerable topographic variation, have included cosmic radiation, which can be modelled 
as a direct function of elevation (1). While concentrations of naturally occurring radionuclides in the 
soil, a major source of gamma radiation, are relatively constant over time, temporal variation due to 
migration and decay of radionuclides from artificial sources, such as the Chernobyl nuclear accident, 
may also be relevant. 
Exposure to terrestrial gamma and cosmic radiation 
In record-based studies, levels of external background gamma radiation in the homes of study 
participants are predicted based on measurements made at other locations throughout the area of study. 
There is considerable heterogeneity between the studies in the types of measurements and methods 
used (Table 3). Both indoor and outdoor measurements have been used for this purpose. Methods for 
assessing exposure in the study population include taking averages over administrative units, simple 
methods of interpolation, and global modelling approaches including kriging methods. The 
computational resolution of the maps ranged between 1x1 km2 (France) and 8x8 km2 (Finland). 
Clearly, these models do not capture all sources of exposure variation. Indoor exposure depends 
strongly on radioactivity in building characteristics including materials, shielding effects and the time 
children spend indoors and outdoors. Even though measured indoor dose rates correlate with outdoor 
dose rates, as shown in Finland as well as in GB (28, 48), exposure estimates derived from indoor 
measurements are anticipated to be more reliable as children spend most of their time indoors. 
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However, if relevant building characteristics are not accounted for in the exposure model and differ 
considerably between children’s homes or between measurement sites and children’s homes, this 
advantage could be lost. Although several studies based exposure assessment on indoor measurements, 
only the Finnish study included information on building type (blocks of flats compared to single-
family houses and terraced houses) in the exposure model.  
Another neglected source of variation are exposures outside the home, such as at schools. The true 
exposure of a child will be a weighted average of exposure at multiple locations within some perimeter 
from their home, suggesting that perfect spatial resolution of exposure models may not be needed for 
accurate prediction of individual exposure.  
Lastly, rainfall can modulate exposure by washing out the decay products of radon, leading to short-
term spikes in measurable radiation levels at ground-level, while snow cover can have a shielding 
effect. The latter may have led to an overestimation of the radiation levels in alpine regions of 
Switzerland, as variations due to snow coverage were not considered.  
There is also heterogeneity in the sources of external background gamma radiation considered for 
exposure assessment. Not all studies included the cosmic component, which is preferable if dose rates 
from cosmic rays vary considerably within the area of study. The studies from Finland and 
Switzerland separately modelled dose contributions originating from the Chernobyl fallout. In 
Switzerland, the dose rates from 137Cs were separately assessed and added to the other components of 
terrestrial radiation without considering temporal variation due to decay and migration of caesium. 
Residential radon 
Compared to gamma dose-rates, radon concentration is more difficult to model, because of large 
spatial variations in the radon potential of underlying soils and the strong dependency on housing 
characteristics and individual behaviour such as ventilation and heating habits. Reliable information 
on these predictors is seldom available. Therefore, there is arguably greater potential for 
misclassification when modelling radon compared to gamma. Again, there is considerable 
heterogeneity between the studies in the methods used to predict radon exposure (Table 4).  
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In the GB study, alternative methods for estimating radon concentrations were tested. The first 
grouped measurements by geological boundaries and grid squares; the second used simple averages 
over County Districts.  Broadly, similar results were obtained with either model (49). 
Radon is the dominant source of effective dose from natural sources of radiation in the general 
population. However, most of this dose is delivered to the lung and the contribution from radon to red 
bone marrow doses, which are relevant for the development of leukaemia, is minor compared to 
ingested radionuclides, terrestrial and cosmic radiation. For children in GB, Kendall et al. (50) 
estimated a mean annual RBM dose at ages 0-14 of 1.4 mSv with radon being responsible for around 
6% of the total dose, while terrestrial gamma rays with directly ionising cosmic rays and ingested 
radionuclides are responsible of 50% and 39% of the total dose, respectively. Harley and Robbins (51) 
have suggested that doses from radon decay products to circulating lymphocytes in the 
tracheobronchial epithelium could be relevant for childhood ALL, although Little et al. (10) concluded 
that it remains reasonable to concentrate attention upon the dose to the RBM when assessing the 
radiation-related risk of childhood leukaemia. 
The effects on childhood leukaemia risks of radon exposure are presumably more difficult to detect 
than those of gamma ray exposure, given a greater potential for exposure misclassification and a lower 
contribution to RBM doses. 
Performance of exposure models 
The performance of exposure models is generally assessed by leaving a set of measurements (test 
sample) out and predict its value based on the remaining measurements (training sample). In such 
internal validation, the coefficients of determination (proportion of variance explained, R2) of models 
used to assess residential radon exposure ranged from 0.20 to 0.40 (Table 4). The Danish study, the 
only study to use an independent dataset for validation (external validation), reported an R2 of 0.45 
(39).  
The performance of models used to estimate exposure to gamma radiation has been rarely assessed. In 
GB, gamma exposure was assessed using a simple county district mean, but in recent years several 
alternative prediction models based on gamma measurements in GB (48, 52, 53) have been devised. 
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The best performance was found for a linear model based on weighted sums of gamma dose rates 
among neighbouring measurement points and other simple models (53), which might be used in future 
studies. In France, the model used to estimate gamma exposure was based on Warnery et al. (41) and 
validated against an independent set of 8,839 dwelling indoor measurements (54). A relatively good 
correlation (r = 0.59) between estimates and measurements was observed, but there was a significant 
difference in mean dose rates (76 vs 55 nSv/h), possibly reflecting a difference between the dental 
surgeries and veterinary clinics, where the measurements used for model development had been made, 
and dwellings. In a sensitivity analysis, using an exposure model based on these 8,839 measurements 
within dwellings (unpublished results) rather than on the 17,404 ones used in the published analyses 
(27, 54), the findings of the study were unchanged. 
To date, there has been no validation of the exposure models used in the reviewed studies based on 
personal dosimetry in children. Such a study could help better understand the errors of the exposure 
models (55).  
Neglected sources of exposure 
Doses from medical uses of radiation and ingested radionuclides have been largely neglected in 
studies of cancer risks from background radiation, because data acquisition is exceedingly difficult, 
particularly without active participation of the study population. The Finnish study evaluated various 
hypothetical bias scenarios due to doses from CT scan examinations, but results were not materially 
affected (28). To the extent that omitted exposures correlate with the exposures that were assessed and 
included in regression models, estimated dose response relationships may be biased. Given a likely 
correlation between exposure to residential radon and exposure to terrestrial gamma radiation (30) , 
(organ-specific) doses from these sources should be combined, but dose conversion models for radon 
exposure are not well established as yet. Detailed information regarding possible correlations between 
these exposures and doses from ingested radionuclides or from medical radiation is lacking. A 
correlation of exposure to gamma radiation or domestic radon with doses from ingested radionuclides 
is plausible as the latter may also depend on local or regional concentrations of naturally occurring 
radionuclides. Such correlations would be more likely if consumed food products are grown locally 
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and drinking water is sourced from local aquifers. To some extent homeostatic control of 40K 
concentrations will reduce the variation in doses from internal emitters in the body, but such 
mechanisms do not apply to other radionuclides (56).  
Residential mobility and timing of exposure assessment 
Another important question that arises in studies of childhood cancer and natural sources of radiation 
is whether complete residential histories are required for accurate assessment of cancer risks. 
Radiation doses from gamma and radon exposure are received continuously over the whole lifetime at 
dose rates that are approximately constant at a given residential location (although radon remediation 
measures could substantially reduce radon exposure). The extent to which cancer risks at a given 
attained age depend on doses received at earlier ages remains unclear. Existing models suggest that 
these relationships differ considerably between cancer types (57). In the absence of an agreed 
alternative weighting scheme, cumulative doses are calculated by (unweighted) integration of dose-
rates from conception (or birth) to attained age. Ideally, this calculation should be based on full 
residential history. However, such data are only available in a few, mainly Nordic countries. In 
Finland, Nikkilä et al. examined the effects of incomplete residential histories on studies of 
background radiation (58). About 48% of cases and controls had lived only at one address and those 
who had relocated generally only moved short distances (median 4km, mean 40km) resulting in small 
differences in exposure levels between successive addresses. Similarly, Demoury et al. found only 
about 34% of children moved to another municipality between birth and diagnosis, and that there was 
a high correlation between exposures at birth and at diagnosis or at inclusion in control group: the 
Pearson correlation coefficient was 0.86 for radon and 0.89 for gamma radiation (27).  Of the 
childhood cancer cases in the study from GB, 44% had not moved residence between birth and 
diagnosis, and about two-thirds were living at diagnosis within 2 km of their birth address (43). Thus, 
in the absence of data on full address histories, the estimation from a single address, despite 
introducing measurement error, should still capture a large proportion of exposure variability between 
individuals. 










































































Potential confounders comprise non-radiation risk factors that are associated with the primary disease 
endpoint and with determinants of radiation exposure from natural sources, such as residential 
location, dwelling characteristics and inhabitants’ living habits. Some factors for which a link with 
childhood cancer is supported by the literature and that might be associated with radiation exposure 
(29, 59) include traffic-related air pollution (60), pesticides (61), exposure to infections (62-66) and 
socioeconomic status (SES) (59, 67-69).  
Such association may also exist for other factors discussed in the literature of childhood cancer, for 
instance: genetic syndromes (47) and birth weight (70). Although all studies had considered some of 
these factors, it is difficult for a single study to include all (Table 1). The studies from France, 
Switzerland and Denmark included a broad range of covariates that showed some correlation with 
gamma or radon exposure. However, these adjustments had little effect on estimates of interest.  
Overall assessment of potential errors and bias 
Despite the methodological challenges, record-based studies have potential to detect and quantify 
childhood cancer risks associated with natural sources of radiation. First, by design, these studies are 
virtually free of selection bias (assuming complete cancer registries and random sample of 
representative controls) and the larger studies are adequately powered. Though exposure assessment is 
difficult, we would argue that the consequences of measurement errors may not be as severe as one 
might expect. The methods of estimating individual exposure to natural sources of radiation in record-
based studies involve interpolation, smoothing of measurements, and thus have a tendency for 
regression to the (local) mean. Arguably, therefore, the dominant component of non-systematic 
exposure measurement error in the discussed studies is of Berkson type, which results in reduced 
precision and statistical power, rather than of classical type, which would lead to bias towards the null. 
Furthermore, exposure models that, to a certain extent, smooth out small-scale variation may even 
improve precision of individual exposure assessment, because children’s true exposure is a time-
weighted average of exposures at the various locations (indoors and outdoors) where they spend most 
of their time. Lastly, the risk of confounding may be minimal, because for most of the suspected risk 
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factors neither the correlations between background gamma or radon nor the effects of the latter on the 
risks of childhood cancer are likely to be strong. Furthermore, in none of the studies did adjustment for 
potential confounders, such as SES, appreciably alter effect estimates.  
Despite these grounds for optimism, the excess cancer risks associated with natural background 
radiation are expected to be small and, consequently, even small biases from unmeasured confounding 
or measurement error could obscure the true effects. In consequence, the potential for bias should not 
be neglected. Indeed, the discrepancies between the results of the reviewed studies might suggest that 
systematic errors are at work in some way.  
Systematic errors in exposure estimates might occur if the measurements on which these are based are 
not representative of exposure levels at the locations where the study subjects spend much of their 
time. However, such errors are unlikely to cause bias in effect estimates unless they differ 
systematically between cases and controls. Other potential sources of systematic error could include 
regional differences in cancer registration coverage that correlate with natural sources of radiation 
levels, neglected exposures, large-scale confounding, ecologic bias or biases associated with 
aggregating (or over-smoothing) the exposure (71), and sampling variation, among others. 
Conclusions and future perspectives  
Recent studies on exposure to natural sources of radiation and childhood cancer have shown 
conflicting results, which remain to be resolved. As we have outlined, these studies face some 
common methodological challenges that should be addressed in future research. We propose some 
steps forward in Box 1. Thanks to the early establishment of national cancer registries in some 
countries, the challenge of achieving sufficient statistical power can now be met. Nevertheless, still 
larger studies or the pooling of studies will be needed to investigate disease subgroups.  
Currently, the greater challenge is to accurately assess children’s exposure for such large study 
populations.  For this, the study groups should learn from each other and join in concerted efforts to 
improve exposure estimation and look for new ways to validate these models with personal dosimetry. 
Quantitative analysis of potential biases associated with exposure misclassification and unmeasured 
confounding could shed light on existing inconsistencies and help study designs in future studies. By 
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addressing these challenges, we are reasonably confident that studies on exposure to natural sources of 
radiation and cancer risks in children can provide an evidence base for a better understanding of the 
effects of low dose ionizing radiation.
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• Increase sample size by including more recent cases and by pooling studies in order to 
assess effects on diagnostic subgroups and cytogenetic subtypes 
• Pool studies that have information on full residential history to assess the effects of 
timing of exposure 
• Optimise and harmonise methodologies for exposure modelling across studies 
• Refine exposure models for gamma radiation by accounting for shielding effects and 
radioactivity of building materials 
• Conduct focused exposure studies that will allow validation of exposure models used:  
o Surveys that assess individual exposure using personal dosimeters and collect 
information on time spent indoors and outdoors, housing characteristics, and 
perimeter of daily movements 
o New measurements at locations where children spend much of their time 
(schools, playgrounds etc.) 
• Refine and harmonise dosimetric calculations of cumulative organ doses throughout 
childhood 
• Include quantitative analysis and simulation of possible biases under realistic assumptions 
of measurement error and residual confounding 










































































Table 1. Characteristics of recent nationwide record-based epidemiological studies on background radiation and childhood cancer 
  Denmark Great Britain Switzerland Switzerland Finland France France Germany 
Study 
Raaschou-Nielsen et 
al.  2008 
Kendall et al. 
2013 
Hauri et al. 2013 
Spycher et al. 
2015 
Nikkilä et al. 2016 
Demoury et al. 
2017 
Demoury et al. 
2017 
Spix et al. 2017 












Period 1968 - 1994  1980 - 2006  
all children living 
in Switzerland 
2000 
 1990-2008 1990 - 2011  1990 – 2009 2002-2007  1987–2011 
Total number of 
cases-controls 
2,400-6,697 27,447-36,793 997 1,782 1,093-3,279 9,056 2,763-30,000 22,652 
Leukaemia cases 1,153 9,058 283 530 1,093 9,056 2,763 13,374 
Brain and CNS 
tumours 
922 6,585 258 423    9,048 
Malignant 
lymphoma 
325 2,319  328     
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2 controls for each 
case of leukaemia, 3 
for 
each case of CNS 
tumour, and 5 for 
each malignant 
lymphoma, matched 
on sex and date of 
birth, randomly 
drawn from registry 
1 or 2 controls per 
case matched on 
sex, date of 
birth and place of 
birth registration 
Resident 
population < 16 
years of age during 
national census in 
2000 
Resident 
population < 16 
years of age 
during national 
censuses in 1990 
and 2000 
3 controls per case 
matched on year of 
birth and gender 
Census data from 








from 1987 - 
2011 for the 
West and 1991 
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Covariates at group 
level 
   

























     
 
 






















Timing of exposure 
residential address 
history 
at birth at census at census 
residential address 
history 
at diagnosis at diagnosis at diagnosis 
Gamma dose range 
(mean) 
----- 




55 - 383 nSv/hr 
(109 nSv/hr) 
Mean: 67.2 nSv/h 
for cases and 66.4 
nSv/h for controls 
65.9 - 260.8 nSv/hr 
(102.6 nSv) 
65.9 - 260.8 
nSv/hr (102.6 
nSv) 
 56.9 – 172.0 
nSv/hr 
(93.3 nSv/h) 












































































4 - 254 Bq/m3  
(48 Bq/m3) 
1.2 - 692 Bq/m3  
(21.3 Bq/m3) 
0.7 - 490.1 Bq/m3  
(86 Bq/m3) 
----- ----- 
12.5 - 819.2 
Bq/m3  
(67.2 Bq/m3) 









Rate ratios for 
cumulative exposure 
Relative risk for 
cumulative 
exposure 
Hazard ratios for 
survival data 
Hazard ratios for 
survival data 





incidence ratio for 
cumulative and at 
place of diagnosis 
exposure 
Odds ratio for 
cumulative and 
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Table 2. Relative risks in recent nationwide record-based epidemiological studies on background radiation and childhood leukaemia 
Source of exposure Country Cases 
Time-place of 
exposure 
Relative risks (95% confidence interval) 




    
 
 
DK 1,153 Full residential history 1.34 (0.97, 1.85)a/ 0.92 (0.69, 1.22)a/ 
 
CH 283 Census  0.90 (0.68,1.19)b/ 1.19 (0.91, 1.57) b/ 
Radon radiation dose 
(mSv) 
    
 
 
GB 9,058 Birth 1.03 (0.96, 1.11)  
 
FR 9,056 Diagnosis  1.00 (0.97, 1.02) - 
Gamma radiation 
dose (mSv) 
    
 
 
GB 9,058 Birth 1.12 (1.03, 1.22)  
 
FI 1,093 Full residential history  0.97 (0.89, 1.06) - 












































































FR 9,056 Diagnosis 1.00 (0.99, 1.01) - 
 
CH 530 Census 1.04 (1.00, 1.08)c/ 1.04 (1.00, 1.08)c/ 









       
9,058  Birth 1.07 (1.01, 1.13) - 
  FR 
       
9,056  Diagnosis 1.00 (0.99, 1.01) - 
Note: data are relative risk (95% confidence intervals) per mSv cumulative equivalent dose to the RBM (if not otherwise indicated).  Abbreviations: FI Finland, GB Great Britain, 
FR France, CH Switzerland, DK Denmark and DE Germany. 
a Per 103 Bq/m3-years 
b Per 100 Bq/m3 
c Per mSv cumulative effective dose (whole body) 
d RR comparing 1.5 vs 0.5 mSv/a for acute lymphoid leukaemia 
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Table 3: Characteristics of models use to assess exposure on gamma radiation in recent record-based epidemiological studies on background radiation and childhood 
cancer 
  Great Britain Switzerland Finland France Germany 
Study Kendall et al. 2013 Spycher et al. 2015 Nikkilä et al. 2016 Demoury et al. 2017 Spix et al. 2017 
Exposure assessment 
Indoor 
dose rates from cosmic and 
terrestrial sources 
Outdoor dose rates from 
cosmic and terrestrial sources 
Indoor and outdoor dose rates 
from terrestrial sources 
Indoor dose rates from 
cosmic and terrestrial sources 
Outdoor annual ambient dose 
rate from terrestrial 
 and cosmic sources 
Sources 
2,283 domestic 
measurements in Great 
Britain 
Airborne spectrometry, 166 
in-situ spectrometry 
measurements, 837 in situ 
dose rate measurements, and 
612 laboratory measurements 
of rock and soil  
346 domestic measurements, 
a mobile survey with 
Geiger-counters and 
spectrometers, 
Municipal averages of dose 
rates, 
Map of Cs-137 activity after 
Chernobyl nuclear accident, 
 - Terrestrial gamma 
radiation:  
14,124 measurements (8,895 
indoor, 5,229 outdoor) and 
14,234 TLD measurements in 
surveillance data. 
- Telluric gamma radiation:  
Map of geogenic uranium 
potential and 97,595 TLD 
measurements in dentist 
1,800 
stations in Germany 
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Building material information 
as an indoor/outdoor factor 
surgeries and veterinary 
clinics 
- Ecological study: average 
municipality exposure 
Type of model County districts mean  
Interpolation using inverse 
distance weighting 
Bivariate interpolation Cokriging 
Interpolation using inverse 
distance weighting 
Geographic resolution County District level 2×2 km2 grid map 8 x 8 km grid map 1 × 1 km2 grid map Community level 
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Table 4. Characteristics of radon exposure assessment in recent record-based epidemiological studies on background radiation and childhood cancer 
  Denmark Great Britain Switzerland France 
Study  Raaschou-Nielsen et al. 2008 Kendall et al. 2013 Hauri et al. 2013 Demoury et al. 2017 
Exposure 
assessment 
Domestic radon concentration Domestic radon concentration Domestic radon concentration Domestic radon concentration 
Sources 3,116 indoor measurements ~400,000 indoor measurements, 35,706 indoor measurements 10,843 measurement of indoor radon 
Predictors 
Geographical region, soil type and 
house characteristics 
Bedrock and superficial geological 
characteristics 
Tectonic units, building information, 
soil texture, urbanization and floor 
level 
concentration and a map of geogenic 
radon potential 
Performance 
R² = 0.45  
(tested against independent 
measurements) 
R² = 0.34 - 0.40 R² = 0.20 R² = 0.32 
Method Linear regression model 
Log-normal modelling based on 
measurements grouped by grid square 
and geological boundaries 
Log-linear regression model Cokriging model 
Geographic 
resolution 
 1 × 1 km2 grid map  1 × 1 km2 grid map 
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